Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lacerda

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Iscience|November 7, 2024
NOD2 protects against allergic lung inflammation in obese female miceRodrigo Rodrigues E-Lacerda, Nicole G Barra, Han Fang, et al.
Physiological Reports|July 5, 2025
NOD1 promotes leukocyte clearance and limits inflammation in female mice during obesity-associated acute lung injuryRodrigo Rodrigues E Lacerda, Nicole G Barra, Han Fang, et al.
STAR Protocols|January 8, 2026
Protocol for determining gut microbiota metabolites as substrates in mouse metabolismHan Fang, Dana Kukje Zada, Nicole G Barra, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 17, 2024
Bruton's tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTKDarryl Y Chan, Nicole G Barra, Han Fang, et al.
Journal of Cardiovascular Electrophysiology|October 13, 2009
Vanoxerine: cellular mechanism of a new antiarrhythmicAntonio E Lacerda, Yuri A Kuryshev, Gan-Xin Yan, et al.
Biomedical Journal|June 1, 2023
Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetesRodrigo Rodrigues E-Lacerda, Han Fang, Nazli Robin, et al.
The Journal of Biological Chemistry|November 15, 1991
Heterologous regulation of the cardiac Ca2+ channel alpha 1 subunit by skeletal muscle beta and gamma subunits. Implications for the structure of cardiac L-type Ca2+ channelsX Y Wei, E Perez-Reyes, A E Lacerda, et al.
Journal of Cardiovascular Electrophysiology|May 28, 2011
Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary resultsIvan Cakulev, Antonio E Lacerda, Celeen M Khrestian, et al.
Journal of Cardiovascular Electrophysiology|October 13, 2009
Vanoxerine, a new drug for terminating atrial fibrillation and flutterNaomichi Matsumoto, Celeen M Khrestian, Kyungmoo Ryu, et al.
The Journal of Biological Chemistry|January 21, 1994
Modification of Ca2+ channel activity by deletions at the carboxyl terminus of the cardiac alpha 1 subunitX Wei, A Neely, A E Lacerda, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Iscience|November 7, 2024
NOD2 protects against allergic lung inflammation in obese female miceRodrigo Rodrigues E-Lacerda, Nicole G Barra, Han Fang, et al.
Physiological Reports|July 5, 2025
NOD1 promotes leukocyte clearance and limits inflammation in female mice during obesity-associated acute lung injuryRodrigo Rodrigues E Lacerda, Nicole G Barra, Han Fang, et al.
STAR Protocols|January 8, 2026
Protocol for determining gut microbiota metabolites as substrates in mouse metabolismHan Fang, Dana Kukje Zada, Nicole G Barra, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 17, 2024
Bruton's tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTKDarryl Y Chan, Nicole G Barra, Han Fang, et al.
Journal of Cardiovascular Electrophysiology|October 13, 2009
Vanoxerine: cellular mechanism of a new antiarrhythmicAntonio E Lacerda, Yuri A Kuryshev, Gan-Xin Yan, et al.
Biomedical Journal|June 1, 2023
Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetesRodrigo Rodrigues E-Lacerda, Han Fang, Nazli Robin, et al.
The Journal of Biological Chemistry|November 15, 1991
Heterologous regulation of the cardiac Ca2+ channel alpha 1 subunit by skeletal muscle beta and gamma subunits. Implications for the structure of cardiac L-type Ca2+ channelsX Y Wei, E Perez-Reyes, A E Lacerda, et al.
Journal of Cardiovascular Electrophysiology|May 28, 2011
Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary resultsIvan Cakulev, Antonio E Lacerda, Celeen M Khrestian, et al.
Journal of Cardiovascular Electrophysiology|October 13, 2009
Vanoxerine, a new drug for terminating atrial fibrillation and flutterNaomichi Matsumoto, Celeen M Khrestian, Kyungmoo Ryu, et al.
The Journal of Biological Chemistry|January 21, 1994
Modification of Ca2+ channel activity by deletions at the carboxyl terminus of the cardiac alpha 1 subunitX Wei, A Neely, A E Lacerda, et al.
Pageof 7